These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6105788)

  • 21. The roles of dopamine and the neurointermediate lobe of the pituitary in the regulation of prolactin secretion during late pregnancy in rats.
    Andrews ZB; Grattan DR
    J Neuroendocrinol; 2004 Oct; 16(10):859-65. PubMed ID: 15500546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine D2 receptors modulate neurotransmitter-regulated calcium ion gates.
    Memo M; Spano PF
    Ann Ist Super Sanita; 1984; 20(1):5-10. PubMed ID: 6099992
    [No Abstract]   [Full Text] [Related]  

  • 23. [D-2 dopamine receptor and hormone release in the intermediate lobe of the pituitary gland].
    Munemura M
    Tanpakushitsu Kakusan Koso; 1986 Feb; 31(2):116-31. PubMed ID: 3014608
    [No Abstract]   [Full Text] [Related]  

  • 24. Prolactin secretion as an index of brain dopaminergic function.
    Thorner MO; Login IS
    Adv Biochem Psychopharmacol; 1981; 28():503-20. PubMed ID: 6452035
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug effects on pre- and postsynaptic dopamine receptors.
    Andén NE; Grabowska-Andén M
    Adv Biochem Psychopharmacol; 1980; 24():57-64. PubMed ID: 6105802
    [No Abstract]   [Full Text] [Related]  

  • 26. Perlapine: relationship between stimulation of prolactin secretion and antipsychotic activity.
    Meltzer HY; Fessler RG; Fang VS
    Psychopharmacology (Berl); 1977 Oct; 54(2):183-6. PubMed ID: 412213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopaminergic mediation of beta-endorphin-induced prolactin secretion.
    Van Loon GR; De Souza EB; Shin SH
    Neuroendocrinology; 1980 Oct; 31(4):293-6. PubMed ID: 6252497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dopaminergic agents in the treatment of hyperprolactinemia].
    Mornex R; Hugues B
    J Pharmacol; 1983; 14 Suppl 3():81-103. PubMed ID: 6369001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of dopamine antagonists on prolactin secretion from cultured rat pituitary cells.
    Denef C; Follebouckt JJ
    Life Sci; 1978 Aug; 23(5):431-5. PubMed ID: 29185
    [No Abstract]   [Full Text] [Related]  

  • 30. Proceedings: Evidence for dopaminergic inhibition of prolactin secretion in the teleost Poecilia latipinna.
    Wigham T; Ball JN
    J Endocrinol; 1974 Nov; 63(2):46P-47P. PubMed ID: 4443712
    [No Abstract]   [Full Text] [Related]  

  • 31. Stimulation of prolactin secretion by metoclopramide in the rat.
    Carlson HE; Briggs JE; McCallum RW
    Proc Soc Exp Biol Med; 1977 Mar; 154(3):475-8. PubMed ID: 847008
    [No Abstract]   [Full Text] [Related]  

  • 32. Evidence that dopamine is a neurotransmitter in the neurointermediate lobe of the hypophysis.
    Holzbauer M; Muscholl E; Racké K; Sharman DF
    Prog Brain Res; 1983; 60():357-64. PubMed ID: 6141589
    [No Abstract]   [Full Text] [Related]  

  • 33. New selective dopamine D-2 antagonists as antipsychotic agents. Pharmacological, chemical, structural and theoretical considerations.
    Högberg T; Rämsby S; Ogren SO; Norinder U
    Acta Pharm Suec; 1987; 24(6):289-328. PubMed ID: 2898864
    [No Abstract]   [Full Text] [Related]  

  • 34. Animal prolactin evidence for antipsychotic activity of piperoxane.
    Gold MS; Redmond DE; Donabedian RK
    Lancet; 1977 Jul; 2(8028):96-7. PubMed ID: 69186
    [No Abstract]   [Full Text] [Related]  

  • 35. [Dopaminergic receptors in the brain].
    Alexandrová M
    Cesk Fysiol; 1984; 33(3):227-40. PubMed ID: 6147203
    [No Abstract]   [Full Text] [Related]  

  • 36. [Mental disorders and prolactin secretion].
    Kordon C; Ruberg M
    Encephale; 1979; 5(2):115-20. PubMed ID: 477592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New concepts in the physiology and pathology: the probable role of dopaminergic neurons in the regulation of the growth of the adenohypophysis].
    Schreiber V
    Ginekol Pol; 1974 Aug; 45(8):937-40. PubMed ID: 4212718
    [No Abstract]   [Full Text] [Related]  

  • 38. A new releasing factor? With biotechnology and a little bit of luck.
    Dannies PS
    Endocrinology; 1997 Dec; 138(12):5085-6. PubMed ID: 9389485
    [No Abstract]   [Full Text] [Related]  

  • 39. Dopamine receptor diversity: molecular and pharmacological perspectives.
    Hartman DS; Civelli O
    Prog Drug Res; 1997; 48():173-94. PubMed ID: 9204687
    [No Abstract]   [Full Text] [Related]  

  • 40. Unresponsiveness of prolactin to repeated injection of sulpiride in man.
    Cohen H; Pugeat M; Tourniaire J; Bertrand J
    Eur J Clin Pharmacol; 1983; 25(2):275-7. PubMed ID: 6628512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.